- Oops!Something went wrong.Please try again later.
Google had hoped to have its workers back in the office starting Jan. 10, but that won't be happening.
Yahoo Finance’s Jared Blikre breaks down the latest Apple earnings report.
Tesla CEO Elon Musk raised eyebrows on Wednesday during the electric vehicle maker's quarterly earnings call when he touted the development of the Optimus humanoid robot.
Certainly you’ve been watching the stock market over the past few days. The recent stock market volatility, following years of up markets, is nevertheless the most widely forecast financial reversal in recent history. For them I offer a fundamental insight, one which can escape even seasoned investors.
Apple beat analysts' expectations on strong performance from its iPhone and services segments.
Moor Insights & Strategy CEO Patrick Moorhead joins Yahoo Finance Live to discuss Intel's fourth quarter earnings, the company's recent stock dip, and the impact of supply shortages.
(Bloomberg) -- Jeremy Grantham got the market’s attention with his “super bubble” call on U.S. stocks. Now he wants to get an even more alarming and urgent message out, one his critics may find harder to accept. Most Read from BloombergA Nor’easter Approaching New York Risks Becoming a Bomb CycloneStock Rebound Fails and Futures Plunge on Earnings: Markets WrapMark Zuckerberg’s Stablecoin Ambitions Unravel With Diem Sale TalksAstronomers Spot Never-Before Seen Object at 4,000 Light-Years AwayNvi
KeyBanc Capital Markets Managing Director Josh Beck joins Yahoo Finance Live to discuss the Robinhood earnings report.
Shares of several big-name electric vehicle (EV) stocks were trading down at midday on Thursday, after category leader Tesla (NASDAQ: TSLA) gave weak guidance for 2022. Lucid Group (NASDAQ: LCID) was down about 9.3%. Nio (NYSE: NIO) was down about 4%.
Yahoo Finance's Jared Blikre reports Visa's quarterly earnings and how the stock is performing.
In this article, we discuss Jim Cramer’s top 10 stock picks for 2022. If you want to skip our detailed analysis of these stocks, go directly to Jim Cramer’s Top 5 Stock Picks for 2022. The beginning of 2022 has not been kind to the stock market. Major indices are down, inflation is up, and […]
Futures rose as Apple rallied on earnings. The market reversed lower Thursday as Tesla plunged on its product roadmap.
The stock price decline comes despite Teradyne reporting better-than-expected fourth-quarter results. Here's what investors should know.
The stock market had another day of intraday volatility on Thursday, with early gains evaporating for major market benchmarks. The Dow Jones Industrial Average (DJINDICES: ^DJI) managed to finish within spitting distance of the unchanged mark, but the further down the market capitalization spectrum you go, the worse various indexes fared. The S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) were successively worse, and small-cap stocks were down more than 2%.
"Dampening" reservations means analyst predictions of a return to profits this year could be all wet.
Shares of Nvidia Corp. tops a list of tech shares that would be expected to bounce back strongly over the next month, according to an artificial-intelligence screening platform.
Intel Corp. weathered another tough investor reaction to its earnings report Thursday despite strong results, as the chip maker faces another challenge in addition to falling margins: A looming oversupply of PCs that promises to hit its largest business segment.
Stock futures opened higher Thursday evening as investors took in earnings results from some major tech companies at the end of another volatile week.
TG Therapeutics Inc's (NASDAQ: TGTX) CEO Michael Weiss said that the FDA has placed a partial clinical hold on some combination candidate studies for leukemia and lymphoma. Speaking at the B. Riley Securities' 2022 Virtual Oncology Investor Conference, Weiss disclosed that FDA placed partial holds on studies of the U2 combination UKONIQ (umbralisib) and ublituximab for chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL). Weiss noted that the updated overall survival (OS) prelimin
With U.S. regulatory approval the only thing left outstanding, AMD and Xilinx now expect to finalize the deal in the first quarter.
(Bloomberg) -- One year after Robinhood Markets Inc. found itself at the center of the meme-stock tempest, the retail brokerage now finds itself with another set of challenges that could prove even more difficult to overcome.Most Read from BloombergApple to Rival Square by Turning iPhones Into Payment TerminalsStocks Drop in Roller-Coaster Ride for Wall Street: Markets WrapCrypto Secrecy Makes DeFi a Financial Felon’s WonderlandHow a Fox News Interview Threw the Antiwork Subreddit Into ChaosAmer